Medchemexpress LLC Simotinib hydrochloride | 944258-89-3 | 99.4% | 500.95 | C25H26ClFN4O4 | 100 MG

Supplier:  Medchemexpress LLC HY101820100MG

Simotinib is a selective, orally bioavailable epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor provided for research and preclinical studies. It exhibits antineoplastic activity by inhibiting EGFR (IC50 19.9 nM) and is supplied as a high-purity analytical standard for laboratory use.

• Selective EGFR tyrosine kinase inhibitor.
• Potent inhibition of EGFR (IC50 19.9 nM).
• Orally bioavailable small molecule suitable for in vitro and preclinical work.
• High purity (99.4%).
• Available in multiple package sizes, including 100 mg.
• Useful for oncology and EGFR signaling research applications.

Catalog No. 50-002-48566